|
| Afternoon Session | Programme |
| Oral Abstracts Presentation – Clinical Science |
2.00 pm
| Phase I PIANO Trial - PIPAC-Oxaliplatin and Systemic Nivolumab Combination for Gastric Cancer Peritoneal Metastases: Clinical and Translational Outcomes
Dr Hon Lyn Tan
Department of Haematology-Oncology, NCIS
|
2.15 pm
| A phase Ib/II study of pacritinib, an interleukin 1 receptor associated kinase 1 (IRAK1) inhibitor, in patients (pts) with solid cancers (Ca) harboring 1q21.3 copy number amplification (CNA)
Dr Joline Lim
Department of Haematology-Oncology, NCIS
|
2.30 pm
| Phase II randomized trial of induction cisplatin and gemcitabine (GP) versus cisplatin, gemcitabine, pembrolizumab and bevacizumab (GPPB) in nasopharyngeal cancer (NPC)
Dr Victor Lee Guan Hui
Department of Medical Oncology, NCIS
|
| Oral Abstracts Presentation -Nursing/Paramedical/Supportive Care |
2.45 pm
| The interplay of healthcare policies, drug costs and ‘time toxicities’ in biologics usage for human epidermal growth factor receptor 2 (HER2) positive breast cancer
Dr Jia Li Low
Department of Haematology-Oncology, NCIS
|
3.00 pm
| Management of burnout in nurses working in a haematology-oncology ward in an acute care hospital: A best practice implementation project
Ms Joanna Ho
Ward 56, NCIS
|
3.15 pm
| Establishing an Advanced Practice Nurse (APN)-Led Breast Cancer Survivorship Clinic at the National University Cancer Institute, Singapore (NCIS): A Year's Experience
Ms Litang Chen
Department of Oncology Nursing, NCIS
|
3.30 pm
| Refreshments |
| Plenary Session |
3.45 pm | Intelligence: the next generation of precision in oncology?
Dr Frank Lin Senior Research Fellow, National Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney |
Hear the Journey Session |
4.15pm
| Unexpected Paths: The Joys of a Young Clinician-Scientist Dr Joshua Tay Consultant, Department of Otolaryngology - Head & Neck Surgery, NUH |
4.35 pm
| Living the best of both worlds: A personal scientific journey A/Prof Su Xin Yi Executive Director, Institute of Molecular and Cell Biology (IMCB) Research Director, Stem Cell and Therapies for Retinal Diseases Lab (IMCB) Senior Consultant, Vitreo-retinal Surgeon, National University Hospital (NUH) Co-Director, Centre of Innovation and Precision Eye Health (NUS) |
| 4.55 pm | Cocktail and networking session |
| 5:30 pm | Announcement of Award Winners |
| 5.45 pm | Closing Address
Prof Chng Wee Joo
Senior Consultant, Department of Haematology-Oncology, NCIS
Professor, Department of Medicine, Yong Loo Lin School of Medicine, NUS
|
